LGC at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

LGC takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 316. Its program centres on virus-like particles, which copy a virus's outer shell without carrying its genes, as tools for early vaccine development. Its Lucigen business supplies enzymes, competent cells and other biological materials for research.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
thenativeantigencompany.com
Reagents, assays & analyticsAssociate sponsor
Its Lucigen reagent components business supplies enzymes, competent cells and other biological materials for diagnostics, drug discovery and gene editing.
Booth
Exhibiting at Booth 316
Talk
Tue Oct 20
14:45
Virus-like particles as tools to support vaccine development
Pre-Clinical Development

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from LGC

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction